Medtronic logo

Medtronic dividend paidNYSE: MDT

TTMAnnual

Dividend paid (quarterly)

$898.00 M
-$15.00 M-1.64%

26 July 2024

-2.18%vs 3 years high
+6.52%vs 3 years low
94.02%vs. sector
Performance
Most recent-1.6%
1 year-2.2%
3 years+6.0%
5 years+24.2%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (quarterly) performance

Most recent change
MDT-1.6%
VRTX-
GILD-1.8%
BMY-0.1%
BSX-
SNY-
ELV0.0%
1 year change
MDT-2.2%
VRTX-
GILD+2.0%
BMY+2.1%
BSX-
SNY-
ELV+8.6%
3 years change
MDT+6.0%
VRTX-
GILD+8.0%
BMY+11.6%
BSX-
SNY-
ELV+37.0%
5 years change
MDT+24.2%
VRTX-
GILD+20.9%
BMY+81.2%
BSX-
SNY-
ELV+85.3%

Dividend paid (quarterly) performance

MDTVRTXGILDBMYBSXSNYELV
Most recent-1.6%--1.8%-0.1%--0.0%
1 year-2.2%-+2.0%+2.1%--+8.6%
3 years+6.0%-+8.0%+11.6%--+37.0%
5 years+24.2%-+20.9%+81.2%--+85.3%
FAQ

What is Medtronic dividend paid (quarterly)?

Medtronic dividend paid (quarterly) is $898.00 M

What is Medtronic dividend paid (quarterly) compared to its all-time maximum value?

Medtronic dividend paid (quarterly) is 97.82% of its all-time maximum value

What is Medtronic dividend paid (quarterly) compared to other companies from its sector (Healthcare)?

Medtronic dividend paid (quarterly) is higher than 94.02% of the companies in the same sector (Healthcare)

How has Medtronic dividend paid (quarterly) changed over the year?

Over the past year, Medtronic dividend paid (quarterly) has dropped by 2.2%. During the same period, , Gilead Sciences has risen by 2.0%, Bristol-Myers Squibb has grown by 2.1%, Elevance Health has grown by 8.6%

How has Medtronic dividend paid (quarterly) changed over the 3 years?

During the last 3 years, Medtronic dividend paid (quarterly) has increased by 6.0%. Over the same period, , Gilead Sciences has risen by 8.0%, Bristol-Myers Squibb has grown by 11.6%, Elevance Health has grown by 37.0%

How has Medtronic dividend paid (quarterly) changed over the 5 years?

For the past 5 years, Medtronic dividend paid (quarterly) has increased by 24.2%. In the same period, , Gilead Sciences has risen by 20.9%, Bristol-Myers Squibb has grown by 81.2%, Elevance Health has grown by 85.3%